Seq&Treat: targeted sequencing for drug-resistant TB detection and treatment
Drug-resistant tuberculosis (DR-TB) is a major contributor to antimicrobial resistance worldwide and continues to be a public health threat. Targeted next-generation sequencing (tNGS) direct from clinical specimens has the potential to transform DR-TB management by providing rapid and comprehensive drug resistance testing to inform timely and treatment, including new shortened drug regimens.
Swapna Uplekar, FIND, presented findings from the recently completed clinical evaluation of the Oxford Nanopore DR-TB test. This evaluation is part of the Unitaid-funded Seq&Treat grant, designed to generate evidence for global policy and accelerate the use of tNGS for DR-TB diagnosis in high TB burden countries.
Смотрите видео Seq&Treat: targeted sequencing for drug-resistant TB detection and treatment онлайн без регистрации, длительностью часов минут секунд в хорошем качестве. Это видео добавил пользователь Oxford Nanopore Technologies 24 Июнь 2024, не забудьте поделиться им ссылкой с друзьями и знакомыми, на нашем сайте его посмотрели 268 раз и оно понравилось 3 людям.